Hughes D C, O'Brien P Q, Brown S R. "Method for the Synthesis of (2R,3R,4S,5R)-5-Methyloxolane-2,3,4-triol" [P]. US Patent, US 11199324 B2, 2020-12-01.
Schröder R, Chen K W, Roberts E F. "A Process for Preparing High-Purity (2R,3R,4S,5R)-5-Methyloxolane-2,3,4-triol" [P]. US Patent, US 11387699 B2, 2019-06-25.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2022, 1440, (9), 8909-8936.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2022, 1457, (10), 2182-2194.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of (2R,3R,4S,5R)-5-Methyloxolane-2,3,4-triol Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2023, 1741, (11), 7996-8010.